An elevation of stem cell factor in patients with hyperthyroid Graves' disease

Thyroid

Volumn 8, Issue 6, 1998, Pages 499-504

  Yamada, Takashi ^a   Sato, Akira ^b   Aizawa, Toru ^c   Ootsuka, Hiromi ^a   Miyahara, Yasuhiro ^a   Sakai, Hideki ^a   Terao, Akira ^a   Onuma, Soshin ^a   Ito, Yoshiharu ^a   Kanamori, Akira ^a   Nakamura, Yutaka ^a   Tejima, Eizaburo ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; STEM CELL FACTOR; THIAMAZOLE; THYROID HORMONE; THYROTROPIN RECEPTOR; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERMETABOLISM; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; SUBACUTE THYROIDITIS; THYROTOXICOSIS; THYROXINE BLOOD LEVEL;

EID: 13144307069     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.499     Document Type: Article

References (24)

1. Weetman AP, McGregor AM. 1994 Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 15:788-830.
2. Burman KD, Baker JR Jr. 1985 Immune mechanism in Graves' disease. Endocr Rev 6:183-232.
3. DeGroot LJ, Quintans J 1989 The causes of autoimmune thyroid disease. Endocr Rev 10:537-562.
4. McKenzie JM, Zakarija M 1995 Antibodies in autoimmune thyroid disease. In Braverman LE, Utiger RD (eds) The Thyroid. 7th ed. Lippincott-Raven, Philadelphia, pp 416-432.
5. Volpé R 1993 The role of cytokines in the development of autoimmune thyroid disease. Thyroid 3:177-178.
6. Celik I, Akalin S, Erbas T 1995 Serum levels of interleukin 6 and tumor necrotic factor-α in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 132:668-672.
7. Galli SJ, Zsebo KM, Geissler EN 1994 The kit ligand, stem cell factor. Adv Immunol 55:1-96.
8. Weetman AP, McGregor AM, Wheeler MH, Hall R 1984 Extrathyroidal sites of autoantibody synthesis in Graves' disease. Clin Exp Immunol 56:330-336.
9. Yoshikawa N, Nishikawa M 1996 Studies on autoimmune thyroid diseases, using SCID mouse (abstract in Japanese). Fol Endocr Japon 72:165.
10. Yamada T, Takasu N, Sato A, Aizawa T, Koizumi Y 1982 Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy. J Clin Endocrinol Metab 54:83-88.
11. Yamada T, Koizumi Y, Sato A, Hashizume K, Aizawa T, Takasu N, Nagata H 1984 Reappraisal of the 3, 5, 3'-tri-iodothyronine-suppression test in the predilection of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease. J Clin Endocrinol Metab 58:676-680.
12. Yamada T, Sato A, Aizawa T 1996 Dissociation between serum interleukin-6 rise and other parameters of disease activity in subacute thyroiditis during treatment with corticosteroid. J Clin Endocrinol Metab 81:577-579.
13. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, et al. 1990 Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203-211.
14. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, et al. 1990 Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-224.
15. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, et al. 1990 Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195-201.
16. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, et al. 1990 Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235-243.
17. Copeland NG, Gilbert DJ, Cho BE, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD, Williams DE 1990 Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63:175-183.
18. Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochizucki DY, Boswell HS, et al. 1990 Identification of a ligand for the c-kit proto-oncogene. Cell 63:167-174.
19. Huang E, Nocka K, Beier DR, et al. 1990 The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-kit receptor, the gene product of the w locus. Cell 63:225-233.
20. Lyman SD, Williams DE 1992 Biological activities and potential therapeutic uses of steel factor. A new growth factor active on multiple hematopoietic leneages. Am J Pediatr Hematol Oncol 14:1-7.
21. Matsui T, Zsebo KM, Hogan BLM 1990 Embryonic expres-sion of a haematopoietic growth factor encoded by the S1 locus and the ligand for c-kit. Nature 347:667-669.
22. Manegold C, Jablonowski H, Armbrecht C, Strohmeyer G, Pietsch T 1995 Serum levels of stem cell factor are increased in asymptomatic human immunodeficiency virus-infected patients and are associated with prolonged survival. Blood 86:243-249.
23. Kimura F, Nakamura Y, Sato K, Wakimoto N, Kato T, Tahara T, Yamada M, Nagata N, Motoyoshi K 1996 Cyclic changes of cytokines in a patients with cyclic thrombocytopenia. Br J Haematol 94:171-174.
24. Langey KE, Bennett LG, Wypych J, Yancik SA, Liu XD, Westcott KR, Chang DG, Smith KA, Zsebo KM 1993 Soluble stem cell factor in human serum. Blood 81:656-660.